Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35Neoplasms 23Motor Activity 11Stomach Neoplasms 7Pain, Postoperative 7Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 7Pain 5Anxiety Disorders 5Polycystic Ovary Syndrome 4Depression 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Stomatitis 3Sleep Initiation and Maintenance Disorders 3Rectal Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Malnutrition 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3Colonic Neoplasms 3Agnosia 3Vomiting 2Urinary Incontinence 2Squamous Cell Carcinoma of Head and Neck 2Parasomnias 2Ovarian Neoplasms 2

Interventions

Echocardiography 4sacubitril and valsartan sodium hydrate drug combination 3Standard of Care 3Nutrition Assessment 3Exercise 3Electrocardiography 3Carvedilol 3dapagliflozin 2Surveys and Questionnaires 2Spironolactone 2Ivabradine 2Blood Specimen Collection 2Atorvastatin 2ziprasidone 1pertuzumab 1pegfilgrastim 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1Zolpidem 1Watchful Waiting 1Warfarin 1Vincristine 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Valsartan 1Trastuzumab 1Tranexamic Acid 1Tobramycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Heart Failure × Control Groups × Clear all
NCT03557255 2018-06-14

Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡